cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with...
TRANSCRIPT
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin,
and cholesteryl ester transfer protein inhibitors
by M. John Chapman, Wilfried Le Goff, Maryse Guerin, and Anatol Kontush
EHJVolume 31(2):149-164
January 14, 2010
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: [email protected]
Pathways of reverse cholesterol transport in man.
M. John Chapman et al. Eur Heart J 2010;31:149-164
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: [email protected]
Comparison of pathways of cholesteryl ester transfer protein-mediated heterotransfer of neutral core lipids between lipoprotein particles in normotriglyceridaemia vs. mixed dyslipidaemia involving moderate to marked hypertriglyceridaemia and subnormal levels of triglyceride-
enriched high-density lipoprotein.
M. John Chapman et al. Eur Heart J 2010;31:149-164
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: [email protected]
Cardiovascular risk remains high despite aggressive statin therapy.
M. John Chapman et al. Eur Heart J 2010;31:149-164
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: [email protected]